Author:
de Leeuw Simon P.,de Bruijn Peter,Koolen Stijn L.W.,Dingemans Anne-Marie C.,Mathijssen Ron H.J.,Veerman G.D. Marijn
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference36 articles.
1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
2. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations;Tan;J. Clin. Oncol.,2022
3. Osimertinib as first-line treatment of EGFR mutation–positive advanced non–small-cell lung cancer;Suresh;J. Clin. Oncol.,2018
4. European Medicines Agency, Alecensa (alectinib): EPAR - Product Information,. 2021.
5. U.S. Food and Drug Administration), Alecensa (alectinib): Highlights of prescribing information. 2021.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献